Detalhe da pesquisa
1.
The IL-15-AKT-XBP1s signaling pathway contributes to effector functions and survival in human NK cells.
Nat Immunol
; 20(1): 10-17, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30538328
2.
TTK/MPS1 inhibitor OSU-13 targets the mitotic checkpoint and is a potential therapeutic strategy for myeloma.
Haematologica
; 109(2): 578-590, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37496433
3.
Aging Phenotypes and Restoring Functional Deficits in Older Adults With Hematologic Malignancy.
J Natl Compr Canc Netw
; 19(9): 1027-1036, 2021 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33770752
4.
Lenalidomide and Vorinostat Maintenance after Autologous Transplantation in Multiple Myeloma: Long- Term Follow-Up.
Biol Blood Marrow Transplant
; 26(1): 44-49, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31518644
5.
Long-Term Follow-up of CALGB (Alliance) 100001: Autologous Followed by Nonmyeloablative Allogeneic Transplant for Multiple Myeloma.
Biol Blood Marrow Transplant
; 26(8): 1414-1424, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32325171
6.
T Cell Transcriptional Profiling and Immunophenotyping Uncover LAG3 as a Potential Significant Target of Immune Modulation in Multiple Myeloma.
Biol Blood Marrow Transplant
; 26(1): 7-15, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31445183
7.
Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function.
Blood
; 132(17): 1792-1804, 2018 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30158248
8.
Comparison of Two Doses of Antithymocyte Globulin in Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(10): 1993-2001, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31229641
9.
BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 25(6): 1107-1115, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30716453
10.
A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma.
Blood
; 129(25): 3294-3303, 2017 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28483761
11.
Anti-leukemic effects of all-trans retinoic acid in combination with Daratumumab in acute myeloid leukemia.
Int Immunol
; 30(8): 375-383, 2018 07 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29868798
12.
Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells.
J Biol Chem
; 291(49): 25656-25666, 2016 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27780867
13.
Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 22(4): 658-668, 2016 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26743340
14.
Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT).
Biol Blood Marrow Transplant
; 22(1): 71-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26256940
15.
A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL).
Blood
; 123(22): 3398-405, 2014 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24615778
16.
Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma.
Blood
; 123(22): 3406-13, 2014 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24615776
17.
Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia.
Blood
; 123(22): 3390-7, 2014 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24615777
18.
Lenalidomide and vorinostat maintenance after autologous transplant in multiple myeloma.
Br J Haematol
; 171(1): 74-83, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26058589
19.
The combination of milatuzumab, a humanized anti-CD74 antibody, and veltuzumab, a humanized anti-CD20 antibody, demonstrates activity in patients with relapsed and refractory B-cell non-Hodgkin lymphoma.
Br J Haematol
; 169(5): 701-10, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25847298
20.
Can NKT cells extinguish smoldering myeloma?
Blood
; 121(3): 418-20, 2013 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23329692